Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Syncytial Virus, Human | 6 | 2021 | 149 | 1.650 |
Why?
|
Viral Fusion Proteins | 7 | 2021 | 100 | 1.310 |
Why?
|
Respiratory Syncytial Virus Infections | 6 | 2021 | 365 | 1.020 |
Why?
|
Antibodies, Neutralizing | 9 | 2021 | 2011 | 0.960 |
Why?
|
Antibodies, Viral | 6 | 2021 | 3216 | 0.780 |
Why?
|
Respiratory Syncytial Viruses | 2 | 2019 | 168 | 0.610 |
Why?
|
Respiratory Syncytial Virus Vaccines | 5 | 2021 | 37 | 0.570 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2015 | 85 | 0.480 |
Why?
|
Viral Proteins | 1 | 2019 | 1802 | 0.400 |
Why?
|
Phosphoproteins | 1 | 2019 | 2451 | 0.350 |
Why?
|
Protein Multimerization | 3 | 2020 | 965 | 0.350 |
Why?
|
Crystallography, X-Ray | 6 | 2020 | 1951 | 0.310 |
Why?
|
Antibody Formation | 2 | 2021 | 1393 | 0.270 |
Why?
|
Epitope Mapping | 2 | 2018 | 301 | 0.250 |
Why?
|
Peptidoglycan | 2 | 2023 | 246 | 0.220 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.220 |
Why?
|
Penicillin-Binding Proteins | 2 | 2023 | 152 | 0.210 |
Why?
|
Models, Molecular | 4 | 2020 | 5403 | 0.200 |
Why?
|
Protein Engineering | 2 | 2024 | 553 | 0.190 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2024 | 404 | 0.180 |
Why?
|
Vero Cells | 2 | 2019 | 486 | 0.180 |
Why?
|
Filoviridae | 1 | 2020 | 15 | 0.180 |
Why?
|
Glycoproteins | 2 | 2020 | 2202 | 0.170 |
Why?
|
Peptidoglycan Glycosyltransferase | 1 | 2020 | 66 | 0.170 |
Why?
|
Spodoptera | 1 | 2019 | 140 | 0.170 |
Why?
|
Hydrogen Bonding | 1 | 2019 | 289 | 0.160 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 393 | 0.150 |
Why?
|
Membrane Transport Proteins | 1 | 2024 | 1037 | 0.150 |
Why?
|
Acetates | 1 | 2019 | 317 | 0.150 |
Why?
|
Crystallization | 1 | 2019 | 520 | 0.150 |
Why?
|
Cryoelectron Microscopy | 2 | 2019 | 648 | 0.150 |
Why?
|
Antiviral Agents | 2 | 2021 | 3073 | 0.140 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2018 | 103 | 0.140 |
Why?
|
Ebolavirus | 2 | 2020 | 250 | 0.140 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2019 | 451 | 0.140 |
Why?
|
Virus Internalization | 1 | 2021 | 504 | 0.140 |
Why?
|
Catalytic Domain | 1 | 2019 | 699 | 0.140 |
Why?
|
HEK293 Cells | 3 | 2024 | 4283 | 0.140 |
Why?
|
Vaccines, Synthetic | 1 | 2019 | 622 | 0.130 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2219 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2021 | 864 | 0.130 |
Why?
|
Protein Conformation | 5 | 2024 | 3956 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2019 | 887 | 0.120 |
Why?
|
Chromatography, Gel | 1 | 2015 | 636 | 0.120 |
Why?
|
Surface Plasmon Resonance | 1 | 2015 | 272 | 0.120 |
Why?
|
Virus Replication | 2 | 2019 | 2458 | 0.110 |
Why?
|
Protein Structure, Quaternary | 1 | 2015 | 426 | 0.110 |
Why?
|
Quinolines | 1 | 2019 | 772 | 0.110 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1110 | 0.110 |
Why?
|
HIV Envelope Protein gp120 | 1 | 2018 | 925 | 0.110 |
Why?
|
Viral Vaccines | 1 | 2019 | 596 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 942 | 0.100 |
Why?
|
HeLa Cells | 1 | 2019 | 3074 | 0.100 |
Why?
|
Viral Envelope Proteins | 1 | 2016 | 640 | 0.100 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6514 | 0.090 |
Why?
|
B-Lymphocytes | 3 | 2019 | 4793 | 0.090 |
Why?
|
Antigens, Viral | 1 | 2015 | 995 | 0.090 |
Why?
|
HIV Antibodies | 1 | 2018 | 1341 | 0.090 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2016 | 424 | 0.090 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9263 | 0.090 |
Why?
|
Structure-Activity Relationship | 3 | 2020 | 3055 | 0.080 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3840 | 0.080 |
Why?
|
Cell Line | 3 | 2021 | 15597 | 0.080 |
Why?
|
Cell Wall | 2 | 2023 | 421 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3814 | 0.070 |
Why?
|
Binding Sites | 3 | 2024 | 6020 | 0.070 |
Why?
|
Computer Simulation | 1 | 2019 | 6283 | 0.060 |
Why?
|
Animals | 8 | 2024 | 169246 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7477 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2015 | 5902 | 0.060 |
Why?
|
Acinetobacter | 1 | 2024 | 39 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6009 | 0.060 |
Why?
|
Epitopes | 2 | 2021 | 2528 | 0.050 |
Why?
|
Protein Binding | 3 | 2021 | 9343 | 0.050 |
Why?
|
Microbial Viability | 1 | 2024 | 237 | 0.050 |
Why?
|
Allosteric Regulation | 1 | 2023 | 426 | 0.050 |
Why?
|
Marburgvirus | 1 | 2020 | 19 | 0.040 |
Why?
|
Biological Availability | 1 | 2021 | 389 | 0.040 |
Why?
|
Peptide Library | 1 | 2021 | 351 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2024 | 1751 | 0.040 |
Why?
|
Biological Transport | 1 | 2024 | 2085 | 0.040 |
Why?
|
Sigmodontinae | 1 | 2018 | 8 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 580 | 0.040 |
Why?
|
Chemokine CX3CL1 | 1 | 2018 | 62 | 0.040 |
Why?
|
Camelids, New World | 1 | 2017 | 20 | 0.040 |
Why?
|
Humans | 14 | 2024 | 768166 | 0.040 |
Why?
|
Ligands | 1 | 2024 | 3284 | 0.030 |
Why?
|
Polysaccharides | 1 | 2023 | 1024 | 0.030 |
Why?
|
Antigens | 1 | 2021 | 1442 | 0.030 |
Why?
|
Molecular Structure | 1 | 2020 | 1883 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1743 | 0.030 |
Why?
|
Perfusion | 1 | 2020 | 1401 | 0.030 |
Why?
|
Cathepsins | 1 | 2016 | 243 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2018 | 1683 | 0.030 |
Why?
|
Respiratory System | 1 | 2018 | 564 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1967 | 0.030 |
Why?
|
Cell Membrane | 1 | 2024 | 3655 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 17140 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2018 | 827 | 0.030 |
Why?
|
Bronchi | 1 | 2018 | 850 | 0.030 |
Why?
|
Antibodies | 1 | 2021 | 2421 | 0.030 |
Why?
|
Drug Discovery | 1 | 2021 | 1068 | 0.030 |
Why?
|
Point Mutation | 1 | 2018 | 1596 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 17569 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2021 | 2682 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3437 | 0.020 |
Why?
|
Monocytes | 1 | 2017 | 2605 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36535 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3703 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 4415 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8054 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14729 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19015 | 0.010 |
Why?
|
Rats | 1 | 2018 | 23760 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9495 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26422 | 0.010 |
Why?
|
HIV-1 | 1 | 2018 | 6961 | 0.010 |
Why?
|
Mice | 2 | 2018 | 82029 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10266 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41754 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42669 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 59629 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30238 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 60066 | 0.010 |
Why?
|
Child | 1 | 2021 | 80917 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89169 | 0.010 |
Why?
|
Male | 2 | 2021 | 364719 | 0.010 |
Why?
|
Aged | 1 | 2021 | 171504 | 0.000 |
Why?
|
Middle Aged | 1 | 2021 | 223492 | 0.000 |
Why?
|
Adult | 1 | 2021 | 223646 | 0.000 |
Why?
|
Female | 1 | 2021 | 397192 | 0.000 |
Why?
|
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_